In an ICU, chaos does not announce itself. It waits for gravity, motion, and one unsecured line. Lindsey Roddy learned that lesson the hard way, watching a routine patient move turn into a near-fatal moment when lifesupport tubing did what physics always does. That moment never faded. It became RoddyMedical, founded in 2018 in Wauwatosa, Wisconsin, by a nurse who understood that patient safety failures rarely look dramatic until they are irreversible.
SecureMove-TLC did not come from a whiteboard fantasy or a consultant’s slide deck. It came from hands that had already lived the problem. Working with Kyle Jansson at the UW-Milwaukee Prototyping Center and later joined by Pat Deno, Lindsey Roddy engineered a wearable medical device that treats medical lines like the mission-critical infrastructure they are. Organized, secured, and built to withstand 80+ lbs of force while competing solutions fail under 4–9. This is not convenience tech. This is consequence tech.
Hospitals noticed. 14 systems across six states put SecureMove-TLC into real clinical use, including Mayo Clinic Phoenix, Barnes-Jewish Hospital, and The Ohio State University Hospital. Mayo Clinic Rochester approved regional deployment across roughly 20 hospitals. Vizient signed a national contract that effectively places RoddyMedical within reach of ~4,000 hospitals. When early mobility stops being a wrestling match with tubing, outcomes change. Discharges come sooner. Hospital-acquired conditions drop. Nurses stop burning 64% of early mobility time untangling problems that never should have existed.
Capital tends to follow clarity. Nurse Capital Fund I stepped in, led by Beth A. Brooks and Marla J. Weston, backing a company built by nurses who understand that frontline insight scales when paired with operational discipline. The investment supports a $5M Series A raise focused on manufacturing expansion, national distribution, and a sales org that scaled from two people to 50+ in October 2025 alone. That kind of growth does not run on optimism. It runs on repeat buyers.
RoddyMedical holds five global patents, secured FDA registration, launched commercially in 2022, and earned recognition from the Mayo Clinic and ASU MedTech Accelerator. Lindsey Roddy leads as CEO with the calm authority of someone who has lived the downside. Kyle Jansson brings engineering rigor forged across 37 iterations. Pat Deno applies decades of manufacturing and go-to-market discipline. Jennifer Metzner keeps the clinical voice sharp and grounded.
19M line dislodgements a year is not a statistic. It is a warning. RoddyMedical listened, built something that holds, and now the market is responding the only way it knows how.
Startups Startup Funding Venture Capital MedTech Medical Devices Wearable Healthcare HealthTech Infrastructure Technology Innovation Tech Ecosystem Startup Ecosystem Hiring Tech Hiring
